Beyond Air (NASDAQ:XAIR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Beyond Air (NASDAQ:XAIR) to a sell rating in a report released on Saturday.

A number of other brokerages have also recently issued reports on XAIR. Weiss Ratings restated a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. D. Boral Capital reiterated a “buy” rating and set a $11.00 target price on shares of Beyond Air in a research report on Wednesday, January 21st. Finally, Rodman & Renshaw assumed coverage on shares of Beyond Air in a research note on Tuesday, January 20th. They issued a “buy” rating for the company. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Beyond Air currently has a consensus rating of “Hold” and an average price target of $11.00.

Beyond Air Price Performance

Shares of NASDAQ XAIR opened at $0.86 on Friday. The company has a current ratio of 5.12, a quick ratio of 4.77 and a debt-to-equity ratio of 2.65. The stock has a fifty day simple moving average of $1.14 and a two-hundred day simple moving average of $1.61. Beyond Air has a 1-year low of $0.67 and a 1-year high of $6.44. The firm has a market cap of $9.05 million, a price-to-earnings ratio of -0.16 and a beta of 0.41.

Beyond Air (NASDAQ:XAIR) last issued its earnings results on Friday, February 13th. The company reported ($0.85) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.54) by ($0.31). The firm had revenue of $2.19 million during the quarter, compared to the consensus estimate of $2.15 million. Beyond Air had a negative net margin of 447.75% and a negative return on equity of 268.82%. Analysts anticipate that Beyond Air will post -0.79 earnings per share for the current year.

Institutional Trading of Beyond Air

A number of large investors have recently modified their holdings of XAIR. Alpine Global Management LLC purchased a new position in shares of Beyond Air during the third quarter worth about $25,000. Osaic Holdings Inc. raised its stake in Beyond Air by 26.4% in the second quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock valued at $29,000 after purchasing an additional 34,000 shares in the last quarter. Virtu Financial LLC purchased a new stake in Beyond Air in the third quarter valued at approximately $48,000. Geode Capital Management LLC lifted its position in Beyond Air by 57.5% during the fourth quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after purchasing an additional 24,695 shares during the last quarter. Finally, Alyeska Investment Group L.P. bought a new stake in Beyond Air during the third quarter valued at approximately $1,753,000. Institutional investors own 31.50% of the company’s stock.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.